Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Nagata, Nobuhiko ^a   Kitasato, Yasuhiko ^b,c   Wakamatsu, Kentaro ^a   Kawabata, Masaharu ^d   Fukushima, Kazuo ^e   Kajiki, Akira ^a   Kitahara, Yoshinari ^a   Watanabe, Kentaro ^f  

^a National Hospital Organization Omuta Hospital   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Minami Kyushu Hospital   (Japan)

^e NHO Kumamoto Saishunsou National Hospital   (Japan)

^f FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; SURFACTANT PROTEIN A;

ADULT; AGED; ARTICLE; BIOPSY; FEMALE; HUMAN; HYPERPLASIA; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS CELL; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REGENERATION; RETROSPECTIVE STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; FEMALE; HUMANS; HYPERPLASIA; IDIOPATHIC INTERSTITIAL PNEUMONIAS; MALE; MIDDLE AGED; PNEUMOCYTES; PROGNOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; REGENERATION; RETROSPECTIVE STUDIES;

EID: 79953083798     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-25     Document Type: Article

References (27)

1. Wells AU, Hansell DM, Rubens MB, Cullinan P, Black CM, du Bois RM. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993, 148:1076-1082.
2. Schwarz DA, Helmers RA, Galvin JR, Van Fossen DS, Frees KL, Dayton CS, Burmeister LF, Hunninghake GW. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994, 149:450-454.
3. Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis: are they helpful for predicting outcome?. Chest 1997, 111:51-57. 10.1378/chest.111.1.51, 8995992.
4. Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ. Idiopathic pulmonary fibrosis; predicting response to therapy and survival. Am J Respir Crit Care Med 1998, 157:1063-1072.
5. American Thoracic Society/European Respiratory Society Idiopathic pulmonary fibrosis: diagnosis and treatment, international consensus statement. Am J Respir Crit Care Med 2000, 161:646-664. American Thoracic Society/European Respiratory Society.
6. King TE, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA, Flint A, Thurlbeck W, Cherniack RM, . Idiopathic pulmonary fibrosis Relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001, 164:1025-1032. Idiopathic pulmonary fibrosis.
7. Rudd RM, Prescott RJ, Chalmers JC, Johnston ID. British Thoracic Society study on cryptogenic fibrosing alveolitis: response to treatment and survival. Thorax 2007, 62:62-66. 10.1136/thx.2005.045591, 2111279, 16769717.
8. McCormack FX, King TE, Voelker DR, Robinson PC, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 1991, 144:160-166.
9. McCormack FX, King TE, Bucher BL, Nielsen L, Mason RJ. Surfactant protein A predicts survival in idiopathic pulmonary fibsosis. Am J Respir Crit Care Med 1995, 152:751-759.
10. Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S. Serum surfactant protein A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000, 162:1109-1114.
11. Greene KE, King TE, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, Nagae H, Mason RJ. Serum surfactant protein-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 2002, 19:439-446. 10.1183/09031936.02.00081102, 11936520.
12. Kinder BW, Brown KK, McCormack FX, Ix J, Kervitsky A, Schwarz MI, King TE. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009, 135:1557-1563. 10.1378/chest.08-2209, 2716710, 19255294.
13. Yokoyama A, Kondo K, Nakajima M, Matsushima T, Takahashi T, Nishimura M, Bando M, Sugiyama Y, Totani Y, Ishizaki T, Ichiyasu H, Suga M, Hamada H, Kohno N. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006, 164-168. 10.1111/j.1440-1843.2006.00834.x, 16548901.
14. Takahashi H, Shiratori M, Kanai A, Chiba H, Kuroki Y, Abe S. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006, S51-S54. 10.1111/j.1440-1843.2006.00809.x, 16423272.
15. Hinata N, Takemura T, Ikushima S, Yanagawa T, Ando T, Okada J, Oritsu M, Koike M. Phenotype of regenerative epithelium in idiopathic interstitial pneumonias. J Med Dent Sci 2003, 50:213-224.
16. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002, 165:277-304.
17. Aherne WA, Dunnill MS. Preparation of tissues: sampling. 1982, 19-32. Morphometry. London: Edward Arnold Ltd, Aherne WA, Dunnill MS.
18. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 166:173-177. 10.1164/rccm.2109039, 12119229.
19. Noth I, Martinez FJ. Recent advances in idiopathic pulmonary fibrosis. Chest 2007, 132:637-650. 10.1378/chest.06-1927, 17699135.
20. Harrod KS, Trapnell BC, Otake K, Korfhagen TR, Whitsett JA. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol 1999, 277:L580-L588.
21. Hickling TP, Sim RB, Malhotra R. Induction of TNF- release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A. FEBS Lett 1998, 437:65-69. 10.1016/S0014-5793(98)01200-9, 9804173.
22. Quintero OA, Korfhagen TR, Wright JR. Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo. Am J Physiol Lung Cell Mol Physiol 2002, 283:L76-L85.
23. Honda Y, Tsunematsu K, Suzuki A, Akino T. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Lung 1988, 166:293-301. 10.1007/BF02714060, 3146676.
24. Hughes DA, Haslam PL. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. Chest 1989, 95:82-89. 10.1378/chest.95.1.82, 2909359.
25. Robinson PC, Watters LC, King TE, Mason RJ. Idiopathic pulmonary fibrosis: abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis 1988, 137:585-591.
26. Low RB. Bronchoalveolar lavage lipids in idiopathic pulmonary fibrosis. Chest 1989, 95:3-5. 10.1378/chest.95.1.3, 2909354.
27. Burkhardt A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 1989, 140:513-524.